UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) February 15, 2007
Matria Healthcare, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| |
|
|
| 0-20619
|
|
20-2091331 |
| |
| (Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| 1850 Parkway Place, Marietta, GA
|
|
30067 |
| |
| (Address of Principal Executive Offices)
|
|
(Zip Code) |
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| |
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| |
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| |
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
| |
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Explanatory Note: Matria Healthcare, Inc. (the “Company”) is filing this amendment to its Current
Report on Form 8-K dated February 15, 2007 (the “Original 8-K”) to correct the amount of restricted
stock grants reported. The paragraph below replaces the second paragraph under the caption
“Restricted Stock Grants” in the Original 8-K.
|
|
|
| Item |
|
5.02(e) Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers |
Restricted Stock Grants
At the February 22, 2007 meeting, the Committee approved restricted stock grants under the
Company’s various stock incentive plans with the amended terms described above. The following
named executive officers whose 2006 compensation will be discussed in the Company’s 2007 proxy
statement received stock grants: Parker H. Petit, Chief Executive Officer, 33,800 shares, Richard
M. Hassett, M.D., President and Chief Operating Officer, 16,500 shares, Jeffrey L. Hinton, Senior
Vice President and Chief Executive Officer, 6,000 shares, Roberta L. McCaw, Senior Vice President,
General Counsel and Corporate Secretary, 6,000 shares, and Yvonne V. Scoggins, Senior Vice
President and Corporate Finance, 6,000 shares.